Boston Cash Flow Overview

BSX Stock  USD 72.91  3.92  5.68%   
Most accounts from Boston Scientific's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Boston Scientific Valuation and Boston Scientific Correlation analysis.
  
At this time, Boston Scientific's Free Cash Flow is fairly stable compared to the past year. Depreciation is likely to rise to about 1.3 B in 2024, despite the fact that Change To Inventory is likely to grow to (627 M).
Most accounts from Boston Scientific's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Boston Scientific Valuation and Boston Scientific Correlation analysis.
At this time, Boston Scientific's Free Cash Flow is fairly stable compared to the past year. Depreciation is likely to rise to about 1.3 B in 2024, despite the fact that Change To Inventory is likely to grow to (627 M).

Boston Scientific cash flow statement Correlations

0.21-0.740.42-0.55-0.680.19-0.92-0.55-0.41-0.56-0.850.580.170.820.52-0.01-0.740.570.040.210.270.2
0.210.160.4-0.390.0-0.1-0.21-0.170.4-0.45-0.150.680.230.060.71-0.270.060.80.15-0.080.030.75
-0.740.160.10.290.710.160.770.230.430.00.110.72-0.290.3-0.63-0.2-0.020.8-0.09-0.170.150.090.05
0.420.40.1-0.54-0.380.2-0.43-0.44-0.23-0.41-0.50.440.920.290.43-0.05-0.110.43-0.070.220.850.15
-0.55-0.390.29-0.540.64-0.130.610.340.690.490.74-0.56-0.25-0.1-0.540.080.51-0.26-0.01-0.18-0.46-0.12
-0.680.00.71-0.380.64-0.070.870.390.640.310.93-0.4-0.17-0.53-0.280.120.6-0.04-0.13-0.11-0.470.17
0.19-0.10.160.2-0.13-0.07-0.11-0.64-0.21-0.47-0.080.140.130.070.16-0.020.12-0.01-0.040.990.26-0.02
-0.92-0.210.77-0.430.610.87-0.110.460.470.490.96-0.62-0.16-0.77-0.52-0.030.72-0.44-0.02-0.14-0.36-0.1
-0.55-0.170.23-0.440.340.39-0.640.460.210.610.41-0.41-0.29-0.34-0.410.440.3-0.25-0.58-0.69-0.39-0.11
-0.410.40.43-0.230.690.64-0.210.470.210.140.63-0.03-0.07-0.070.02-0.140.570.360.11-0.24-0.440.48
0.0
-0.56-0.450.11-0.410.490.31-0.470.490.610.140.38-0.68-0.16-0.41-0.690.40.2-0.54-0.18-0.48-0.39-0.46
-0.85-0.150.72-0.50.740.93-0.080.960.410.630.38-0.5-0.25-0.63-0.41-0.050.73-0.30.0-0.12-0.450.05
0.580.68-0.290.44-0.56-0.40.14-0.62-0.41-0.03-0.68-0.50.130.390.99-0.2-0.240.660.120.130.250.73
0.170.230.30.92-0.25-0.170.13-0.16-0.29-0.07-0.16-0.250.130.180.12-0.020.110.26-0.110.140.79-0.01
0.820.06-0.630.29-0.1-0.530.07-0.77-0.34-0.07-0.41-0.630.390.180.310.0-0.480.54-0.040.060.20.13
0.520.71-0.20.43-0.54-0.280.16-0.52-0.410.02-0.69-0.410.990.120.31-0.19-0.20.680.110.150.220.76
-0.01-0.27-0.02-0.050.080.12-0.02-0.030.44-0.140.4-0.05-0.2-0.020.0-0.19-0.2-0.04-0.76-0.05-0.15-0.27
-0.740.060.8-0.110.510.60.120.720.30.570.20.73-0.240.11-0.48-0.2-0.2-0.21-0.120.05-0.030.2
0.570.8-0.090.43-0.26-0.04-0.01-0.44-0.250.36-0.54-0.30.660.260.540.68-0.04-0.21-0.05-0.010.040.67
0.040.15-0.17-0.07-0.01-0.13-0.04-0.02-0.580.11-0.180.00.12-0.11-0.040.11-0.76-0.12-0.050.03-0.030.07
0.21-0.080.150.22-0.18-0.110.99-0.14-0.69-0.24-0.48-0.120.130.140.060.15-0.050.05-0.010.030.27-0.07
0.270.030.090.85-0.46-0.470.26-0.36-0.39-0.44-0.39-0.450.250.790.20.22-0.15-0.030.04-0.030.27-0.16
0.20.750.050.15-0.120.17-0.02-0.1-0.110.48-0.460.050.73-0.010.130.76-0.270.20.670.07-0.07-0.16
Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(290M)(65M)(346M)(321M)(660M)(627M)
Change In Cash(222M)1.4B173M(1.0B)(71M)(67.5M)
Free Cash Flow1.4B1.1B1.3B914M1.7B1.8B
Depreciation1.0B1.1B1.1B1.1B1.2B1.3B
Other Non Cash Items551M337M17M540M253M438.3M
Net Income4.7B(82M)1.0B698M1.6B1.7B
End Period Cash Flow607M2.0B2.2B1.1B1.1B673.8M
Investments(348M)(146M)15M56M(1.7B)(1.6B)
Change Receivables(130M)335M(279M)(220M)(198M)(188.1M)
Net Borrowings1.4B2.8B(999M)(165M)(189.8M)(180.3M)
Change To Netincome312M205M100M410M369M516.1M

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boston Stock

  0.69HQY HealthEquity Financial Report 3rd of June 2024 PairCorr

Moving against Boston Stock

  0.91SINT SINTX TechnologiesPairCorr
  0.8RSLS ReShape LifesciencesPairCorr
  0.74BBLG Bone Biologics Corp Financial Report 20th of May 2024 PairCorr
  0.73HCAT Health Catalyst Upward RallyPairCorr
  0.72HSDT Helius Medical Techn Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.
The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.856
Earnings Share
1.07
Revenue Per Share
9.8
Quarterly Revenue Growth
0.149
Return On Assets
0.0447
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.